Triveni Bio
Bhaskar Srivastava currently serves as the Chief Medical Officer at Triveni Bio. Previously, Bhaskar held various leadership positions at Nimbus Therapeutics, including Senior Vice President of Clinical Development and Vice President of Early Clinical Development. At The Janssen Pharmaceutical Companies of Johnson & Johnson, roles included Senior Director of Early Development Translational Science and Medicine in Immunology, Director of Early Development and Translational Medicine, and Director of Medical Affairs in Dermatology. In addition, Bhaskar was the Dermatology Director of Clinical Innovation at Reliant Medical Group and Lead Dermatologist at Cornell Scott - Hill Health Corporation. Bhaskar earned an MD and PhD from the University of Pennsylvania School of Medicine between 1999 and 2007 and holds a Bachelor's Degree in Biochemistry from Harvard University, obtained from 1995 to 1999.
This person is not in any teams
Triveni Bio
Triveni Bio is a biotech company pioneering a genetics-informed precision medicine approach to develop functional antibodies for the treatment of I&I disorders. The company’s approach establishes proof-of-concept at the earliest stages of drug development. Through a strong understanding of genetics and mechanistic biology, our pipeline is powered for indication expansion where we know we can have the most impact. To learn more, visit www.triveni.bio.